Back

Co-transcriptional capping using an RNA capping enzyme-T7 RNA polymerase fusion protein

Chan, S. H.; Tirole, L.; Kneller, D. W.; Kelley, T. M.; Dai, N.; Robb, G. B.

2023-10-28 biochemistry
10.1101/2023.10.28.564488 bioRxiv
Show abstract

mRNA vaccines and therapeutics are highly effective and can be developed and manufactured with a relatively short lead time. Here we report an all-enzyme platform to generate capped synthetic RNA in a one-step process based on an RNA capping enzyme-T7 RNA polymerase fusion protein. Under standard in vitro transcription reaction conditions, the fusion protein, in conjunction with an RNA cap 2'-O-methyltransferase, can generate synthetic mRNA with up to 95% of Cap-1 incorporation, greatly simplifying mRNA manufacturing workflows.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.